Australian Institute of Sport (AIS) Sports Supplement Framework
NTLA-2002 is undergoing further clinical investigation in the phase 3, global, multicentre, randomised, double-blind, placebo-controlled HAELO study (NCT06634420) as potentially the first in vivo, one-time gene editing treatment for HAE
Yet behind the surge lies a bigger shift: pharma companies are turning to direct-to-consumer (DTC) telehealth platforms as a new marketing and distribution channel
"Over time, this may help lower the risk of chronic inflammatory conditions." That said, results are mixed, with some studies showing no significant effect of green tea on markers of inflammation
Liu L, Sakakibara K, Chen Q, Okamoto K
In This Article What Is Retatrutide